Source: Entourage Health Corp.
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Entourage Health Corp. (ENTG) has signed an exclusive licensing, manufacturing and distribution agreement with Irwin Naturals Inc
  • The new line of CBD and THC products to be produced under the agreement are curated by Entourage alongside Irwin’s wholly-owned subsidiary Irwin Naturals Cannabis
  • The terms of the agreement stipulate that Entourage will manufacture the newly formulated suite of Irwin-branded line of softgels in five different varieties
  • Entourage Health Corp is a licence holder producing and distributing cannabis products for both the medical and adult-use markets
  • Entourage Health Corp. opened trading at $0.05 per share

Entourage Health (ENTG) has signed an exclusive licensing, manufacturing and distribution agreement with Irwin Naturals (IWIN).

The new line of CBD and THC products to be produced under the agreement are curated by Entourage alongside Irwin’s wholly-owned subsidiary Irwin Naturals Cannabis.

They are expected to be launched first on Entourage’s Starseed Medicinal channel in Q4, 2022. After that, they will be moved to retail markets across Canada.

The agreement stipulates that Entourage will manufacture the newly formulated suite of Irwin-branded line of softgels in five different varieties: CBD, THC and three additional formulations that include both THC and another cannabinoid.

As a result of recent recommendations issued by Health Canada’s Science Advisory Committee on Health Products Containing Cannabis, the Irwin-branded CBD products could eventually launch over-the-counter in pharmacies across Canada.

“With Irwin’s highly regarded portfolio of products and brand loyalty coupled with our expertise in medical cannabis, we are introducing a game-changing pairing that will debut an array of Irwin Naturals-branded cannabis products in unique THC and CBD formulations,” said George Scorsis, Executive Chairman and CEO, Entourage.

“We’ve set out to become the first household brand to have its products available on dispensary shelves across America, and this partnership with Entourage takes that plan international, pairing our trusted, proven herbal supplement business with a cutting-edge cannabis company to open a new frontier in our business,” stated Klee Irwin, CEO of Irwin Naturals.

Entourage Health Corp is a licence holder producing and distributing cannabis products for medical and adult-use markets.

Irwin Naturals is a herbal supplement formulator which is now leveraging its brand to enter into both the cannabis and psychedelic industries.

Entourage Health Corp. opened trading at $0.05 per share.


More From The Market Herald

" Columbia Care (CSE:CCHW) launches Seed & Strain pre-rolls in New York

Columbia Care’s (CCHW) Seed & Strain pre-rolls are now available at its four dispensaries in New York.

" The Market Herald’s Weekly Cannabis Report. August 12, 2022

Aleafia Health (TSX:AH) earns record quarter-over-quarter revenue in Q1 2023

" Christina Lake Cannabis (CSE:CLC) recaps Q2 results

Christina Lake Cannabis (CLC) recap its second quarter financial results for the six-month period ended May 31, 2022.

" Aleafia Health (TSX:AH) earns record quarter-over-quarter revenue in Q1 2023

Aleafia Health (AH) reported its financial results for the three months ended June 30, 2022.